In this study, our data demonstrated that both RC402 and RP116 exhibited anti-tumor effects against BCC lines that expressed JAM-A, and these effects increased over time, with RP116 showing particularly significant efficacy (Figs. 1 and 2). This evidence concerns the gene F11R and neoplasm.